251
Views
13
CrossRef citations to date
0
Altmetric
Special Section - Original Research

Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans

, PhD, , PhD, , MD, MPH, , MPH, , MS & , MD
Pages 82-87 | Received 11 Jun 2015, Accepted 28 Sep 2015, Published online: 01 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ingrid A. Binswanger & Adam J. Gordon. (2016) From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field. Substance Abuse 37:1, pages 1-3.
Read now

Articles from other publishers (12)

Barbara Andraka-Christou, Elizabeth McAvoy, Adam J Gordon, Maggie Ohama, Marilyn Brach, Erin A Taylor, Mary Vaiana, Brendan Saloner & Bradley D Stein. (2023) Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022. Pain Medicine 24:12, pages 1306-1317.
Crossref
Rachel E. Barenie, Brian T. Bateman, Hilary S. Connery, Theodore Tsacogianis & Aaron S. Kesselheim. (2023) Rates and costs of drug testing practices for private payors in the outpatient setting in the United States, 2015–2019. Journal of Substance Use and Addiction Treatment, pages 209243.
Crossref
Noelle G. Martinez, Sarah C.M. Roberts, Rachel A. Achu-Lopes, Tirah L. Samura, Dominika L. Seidman & Elisabeth J. Woodhams. (2023) Reconsidering the use of urine drug testing in reproductive settings. American Journal of Obstetrics & Gynecology MFM 5:12, pages 101206.
Crossref
Laila Khalid, Chinazo O. Cunningham, Yuting Deng, Mariya Masyukova, Joel Bumol, Ana Valle, Chenshu Zhang & Tiffany Lu. (2022) Cascade of care for office-based buprenorphine treatment in Bronx community clinics. Journal of Substance Abuse Treatment 139, pages 108778.
Crossref
Chinazo O. Cunningham, Laila Khalid, Yuting Deng, Kristine Torres-Lockhart, Mariya Masyukova, Shenell Thomas, Chenshu Zhang & Tiffany Lu. (2022) A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic. Journal of Substance Abuse Treatment 135, pages 108641.
Crossref
Sarah B Andrea, Tess A Gilbert, Benjamin J Morasco, Somnath Saha & Kathleen F Carlson. (2021) Factors Related to Prescription Drug Monitoring Program Queries for Veterans Receiving Long-Term Opioid Therapy. Pain Medicine 22:7, pages 1548-1558.
Crossref
Krishnan Chakravarthy, Aneesh Goel, George M. Jeha, Alan David Kaye & Paul J. Christo. (2021) Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?. Current Pain and Headache Reports 25:2.
Crossref
Timothy M Benedict, Patrick G Keenan, Arthur J Nitz & Tobias Moeller-Bertram. (2020) Post-Traumatic Stress Disorder Symptoms Contribute to Worse Pain and Health Outcomes in Veterans With PTSD Compared to Those Without: A Systematic Review With Meta-Analysis. Military Medicine 185:9-10, pages e1481-e1491.
Crossref
Kenneth B Chapman, Martijn M Pas, Diana Abrar, Wesley Day, Kris C Vissers & Noud van Helmond. (2020) Development and Performance of a Web-Based Tool to Adjust Urine Toxicology Testing Frequency: Retrospective Study. JMIR Medical Informatics 8:4, pages e16069.
Crossref
Dhanalakshmi Koyyalagunta, Eduardo Bruera, Mitchell P Engle, Larry Driver, Wenli Dong, Chris Demaree & Diane M Novy. (2018) Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain. Pain Medicine 19:7, pages 1469-1477.
Crossref
Charles E Argoff, Daniel P Alford, Jeffrey Fudin, Jeremy A Adler, Matthew J Bair, Richard C Dart, Roy Gandolfi, Bill H McCarberg, Steven P Stanos, Jeffrey A Gudin, Rosemary C Polomano & Lynn R Webster. (2018) Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations. Pain Medicine 19:1, pages 97-117.
Crossref
Gagan Mahajan. (2017) Role of Urine Drug Testing in the Current Opioid Epidemic. Anesthesia & Analgesia 125:6, pages 2094-2104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.